bispecific antibody

Lilly bolts on cancer bispecifics with $1.6bn Merus alliance

https://pharmaphorum.com/news/lilly-bolts-on-cancer-bispecifics-with-1-6bn-merus-alliance/

Denmark’s Genmab raises a bumper $500m-plus in Nasdaq IPO

https://pharmaphorum.com/news/denmarks-genmab-raises-a-bumper-500m-plus-in-nasdaq-ipo/

Novartis buys into bispecific antibodies with Xencor deal

https://pharmaphorum.com/news/novartis-signs-150m-antibody-deal-xencor/

Close in 10 seconds

Pharmaphorum.com

Search